Optical Coherence Tomography Angiography in Myopic Patients

October 19, 2019 updated by: M. Tarek A. Moustafa, Minia University

Evaluation of Macular Microvasculature in High Myopia Using Optical Coherence Tomography Angiography

The aim of this study is to investigate the macular microvascular network alterations in high myopic eyes using optical coherence tomography angiography.

Study Overview

Status

Completed

Conditions

Detailed Description

High myopia is defined as a refractive error equal to or more than -6 D, and/or axial length equal to or more than 25.5 mm².Axial elongation of the globe and subsequent stretch of the retina leads to sight threatening complications.

Quantitative measurements of retinal vasculature in the healthy eye have been reported using several in vivo and in vitro techniques, including confocal microscopy, fluorescein angiography (FA), and swept-source optical coherence tomography (ssOCT) angiography.

The aim of this study is to investigate the macular microvascular network alterations in high myopic eyes using optical coherence tomography angiography.

This cross-sectional prospective study included 75 eyes of 54 patients, they were recruited from the outpatient clinic of ophthalmology department of El-Minia university hospital.They were divided into two groups, group A included 25 normal eyes of 25 patients. Group B included 50 myopic eyes of 30 patients.

All patients subjected to history taking and full ophthalmological examination in addition to axial length measurment before performing OCTA.

Study Type

Observational

Enrollment (Actual)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minia
      • Minya, Minia, Egypt, 61111
        • Minia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Groiup A patients were chosen when met the inclusion criteria. Group B individuals were chosen among healthy age-matched controls.

Description

Inclusion Criteria:

  • • Highly myopic subjects, defined as those with spherical equivalents (SEs) of -6 or more, with axial length greater than 26.5 mm.

Group B individuals were chosen among healthy age-matched controls.

Exclusion Criteria:

  • • Patients younger than 18 years old, or older than 45 years.

    • Any patient with macular pathology (e.g. diabetic retinopathy, hypertensive retinopathy, dystrophy)
    • Myopic patients with any vitro-retinal abnormalities (e.g. choroidal neovascular membrane (CNVM), foveoschisis,macular hole)
    • Patients who underwent previous intra ocular surgical procedures.
    • Patients with previous history of intraocular injections.
    • Glaucomatous patients.

Exclusion criteria to the images that has been captured:

  • - Low signal strength index (less than 50).
  • - Presence of blink artefacts.
  • - Poor fixation leading to motion or doubling artefacts.
  • - Media opacity obscuring view of the vasculature.
  • - Segmentation error due to cystoid macular oedema or epi-retinal membrane, among others.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy controls
Healthy individuals of age-matched
Macular scanning using regular structural OCT as well as microvasculature analysis using OCTA
Other Names:
  • OCTA
Myopic patients
Patients with myopia who meet the inclusion criteria
Macular scanning using regular structural OCT as well as microvasculature analysis using OCTA
Other Names:
  • OCTA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in angiography between the 2 groups
Time Frame: through study completion, an average of 4 weeks
The difference of the volumetric data generated automatically from the OCTA machine at the 3 levels, (the inner retina, outer retina and the choriocapillaris) in three zones (the fovea, the parafovea and the whole image)
through study completion, an average of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: M. Tarek A Mosutafa, MD, Lecturer of ophthalmology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

January 1, 2019

Study Completion (Actual)

June 1, 2019

Study Registration Dates

First Submitted

October 12, 2019

First Submitted That Met QC Criteria

October 19, 2019

First Posted (Actual)

October 22, 2019

Study Record Updates

Last Update Posted (Actual)

October 22, 2019

Last Update Submitted That Met QC Criteria

October 19, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 68-7/2018

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Optical coherence tomography angiography OCTA

Subscribe